findmyKOL
Clinical trialNCT06662942RecruitingPhase 1Interventional

StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms

SponsorAndrew T. Goldstein, MDEnrollment100Vulvar Lichen Sclerosus
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is designed to evaluate the efficacy and safety of StrataMGT for the management of vulvar lichen sclerosus symptoms.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Centers for Vulvovaginal Disorders, Dc

    Washington D.C., District of Columbia, United States

    Recruiting
  • Centers for Vulvovaginal Disorders, Fl

    Tampa, Florida, United States

    Recruiting
  • Centers for Vulvovaginal Disorders, Ny

    New York, New York, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboStrataMGT
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
16 Oct 2024
Primary completion
16 Oct 2025
Completion
16 Oct 2025
Last update posted
8 Nov 2024
Registered enrollment
100
Registry id
NCT06662942
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.